Canurta Therapeutics Website
2 known investors
Canurta Therapeutics develops multi-target botanical drugs using its AI-backed PolyKye platform to identify bioactive compounds and guide compound selection, disease targeting, and formulation. Its therapies target inflammation and neurological diseases, with a lead candidate (CNR-401) aimed at Amyotrophic Lateral Sclerosis (ALS).
Founders & leadership
AG
Akeem GardnerinFounder · Chief Executive Officer
Investors · 2
Frequently asked questions
- What does Canurta Therapeutics Website do?
- Canurta Therapeutics develops multi-target botanical drugs using its AI-backed PolyKye platform to identify bioactive compounds and guide compound selection, disease targeting, and formulation. Its therapies target inflammation and neurological diseases, with a lead candidate (CNR-401) aimed at Amyotrophic Lateral Sclerosis (ALS).
- Who founded Canurta Therapeutics Website?
- Canurta Therapeutics Website was founded by Akeem Gardner.
- Who are Canurta Therapeutics Website's investors?
- Canurta Therapeutics Website's investors include Innovative Solutions Canada, Waterloo Accelerator Centre.